The Oncology Institute, Inc. is a value-based oncology company. The Company manages community-based oncology practices which serve patients at approximately 86 clinic locations across 16 markets and five states throughout the United States. The Company's segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion, radiation, and programs like outpatient blood product transfusions, along with 24/7 patient support. The Company, through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. The Company also provides management services to over 14 clinic locations owned by independent oncology practices. The Company and its affiliated providers have contractual relationships with payors serving a variety of patients, including Medicare Advantage (MA), Medicaid, and commercial patients.
์ข
๋ชฉ ์ฝ๋ TOI
ํ์ฌ ์ด๋ฆOncology Institute Inc
์์ฅ์ผMar 13, 2020
CEOVirnich (Daniel)
์ง์ ์825
์ ํOrdinary Share
ํ๊ณ ์ฐ๋ ์ข
๋ฃMar 13
์ฃผ์18000 Studebaker Rd
๋์CERRITOS
์ฆ๊ถ ๊ฑฐ๋์NASDAQ OMX - NASDAQ BASIC
๊ตญ๊ฐUnited States of America
์ฐํธ ๋ฒํธ90703
์ ํ15627353226
์น์ฌ์ดํธhttps://theoncologyinstitute.com/
์ข
๋ชฉ ์ฝ๋ TOI
์์ฅ์ผMar 13, 2020
CEOVirnich (Daniel)
์ง๋ 5๋
๋์ ์ด
0.00
USD์ ๋ฐฐ๋น๊ธ์ด ๋ถ๋ฐฐ๋์์ต๋๋ค.

๋ฐ์ดํฐ ์์